<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Reuters: Health News</title><link>http://www.reuters.com</link><description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description><language>en-us</language><copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. © Reuters 2013</copyright><pubDate>Sat, 25 May 2013 05:14:03 GMT</pubDate><lastBuildDate>Sat, 25 May 2013 05:14:03 GMT</lastBuildDate><ttl>5</ttl><image><title>Reuters: Health News</title><url>http://www.reuters.com/resources_v2/images/reuters125.png</url><link>http://www.reuters.com</link></image><feedburner:info uri="reuters/healthnews" /><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.reuters.com/reuters/healthNews" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/DrTanelianHealthNews" /><feedburner:info uri="drtanelianhealthnews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item><title>Exclusive: 'Workplace wellness' fails bottom line, waistlines - RAND</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/u3HrX0bFr0w/story01.htm</link><description>NEW YORK (Reuters) - A long-awaited report on workplace wellness programs, which has still not been publicly released, delivers a blow to the increasingly popular efforts, Reuters has learned, casting doubt on a pillar of the Affordable Care Act and a favorite of the business community.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c605284/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=u3HrX0bFr0w:RfoqLec0FMI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=u3HrX0bFr0w:RfoqLec0FMI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=u3HrX0bFr0w:RfoqLec0FMI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=u3HrX0bFr0w:RfoqLec0FMI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=u3HrX0bFr0w:RfoqLec0FMI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/u3HrX0bFr0w" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 22:39:55 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-wellness-idUSBRE94N0XX20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c605284/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Ewellness0EidUSBRE94N0AXX20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Certain chronic pain may raise suicide risk</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/iZG3zVW_p4E/story01.htm</link><description>NEW YORK (Reuters Health) - Back pain, migraine and other types of chronic pain without a known physical cause - and therefore little prospect for relief - were associated with an increased risk of suicide in a new study of U.S. veterans.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c6024bf/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=iZG3zVW_p4E:lqldutcR37Q:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=iZG3zVW_p4E:lqldutcR37Q:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=iZG3zVW_p4E:lqldutcR37Q:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=iZG3zVW_p4E:lqldutcR37Q:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=iZG3zVW_p4E:lqldutcR37Q:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/iZG3zVW_p4E" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 21:28:15 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-chronic-pain-idUSBRE94N0WQ20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c6024bf/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Echronic0Epain0EidUSBRE94N0AWQ20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Some with defibrillators may safely play sports</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/ul3QEY32wc4/story01.htm</link><description>NEW YORK (Reuters Health) - Despite expert guidelines advising against intense sports activity for people with implanted heart defibrillators, a new study suggests that some can compete without serious consequences.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5f8256/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=ul3QEY32wc4:Wf6ZOwWM4IY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=ul3QEY32wc4:Wf6ZOwWM4IY:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ul3QEY32wc4:Wf6ZOwWM4IY:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=ul3QEY32wc4:Wf6ZOwWM4IY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ul3QEY32wc4:Wf6ZOwWM4IY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/ul3QEY32wc4" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 20:41:34 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-defibrillators-idUSBRE94N0VZ20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5f8256/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Edefibrillators0EidUSBRE94N0AVZ20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>New U.S. fears emerge over tainted compounded steroids</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/b4Ao3xH5kok/story01.htm</link><description>(Reuters) - The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5ecfa5/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664306895/u/49/f/654207/c/35217/s/2c5ecfa5/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664306895/u/49/f/654207/c/35217/s/2c5ecfa5/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664306895/u/49/f/654207/c/35217/s/2c5ecfa5/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=b4Ao3xH5kok:OGsa9iJgw5g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=b4Ao3xH5kok:OGsa9iJgw5g:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=b4Ao3xH5kok:OGsa9iJgw5g:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=b4Ao3xH5kok:OGsa9iJgw5g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=b4Ao3xH5kok:OGsa9iJgw5g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/b4Ao3xH5kok" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 20:26:40 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-usa-health-warning-idUSBRE94N0T820130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5ecfa5/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Eusa0Ehealth0Ewarning0EidUSBRE94N0AT820A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Valeant near deal to acquire Bausch &amp; Lomb: source</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/f6sxWD95pbM/story01.htm</link><description>NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch &amp; Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5e984c/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=f6sxWD95pbM:z0OumsflSaw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=f6sxWD95pbM:z0OumsflSaw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=f6sxWD95pbM:z0OumsflSaw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=f6sxWD95pbM:z0OumsflSaw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=f6sxWD95pbM:z0OumsflSaw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/f6sxWD95pbM" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 20:16:33 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-valeant-bauschlomb-idUSBRE94N0PM20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5e984c/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Evaleant0Ebauschlomb0EidUSBRE94N0APM20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>New bird flu may be capable of human to human spread - study</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/URjF3AEEc3g/story01.htm</link><description>HONG KONG (Reuters) - The new H7N9 bird flu virus can be transmitted between mammals not only via direct contact but also in airborne droplets, and may be capable of spreading from person to person, Chinese and American researchers have found.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5963d0/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=URjF3AEEc3g:I4xQXn90NMw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=URjF3AEEc3g:I4xQXn90NMw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=URjF3AEEc3g:I4xQXn90NMw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=URjF3AEEc3g:I4xQXn90NMw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=URjF3AEEc3g:I4xQXn90NMw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/URjF3AEEc3g" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 16:09:54 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-hongkong-birdflu-idUSBRE94N0AR20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5963d0/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Ehongkong0Ebirdflu0EidUSBRE94N0AAR20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>C-sections tied to child obesity</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/k9JnObJaWTc/story01.htm</link><description>NEW YORK (Reuters Health) - More babies born via cesarean section grow up to be heavy kids and teens than those delivered vaginally, according to a new study of more than 10,000 UK infants.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5dbbe0/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=k9JnObJaWTc:x5jVObfe-bs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=k9JnObJaWTc:x5jVObfe-bs:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=k9JnObJaWTc:x5jVObfe-bs:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=k9JnObJaWTc:x5jVObfe-bs:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=k9JnObJaWTc:x5jVObfe-bs:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/k9JnObJaWTc" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 16:09:20 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-c-sections-tied-to-child-obesity-idUSBRE94N0NS20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5dbbe0/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Ec0Esections0Etied0Eto0Echild0Eobesity0EidUSBRE94N0ANS20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>WHO to help Saudi Arabia investigate coronavirus before haj</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/7xbgUaa5qWc/story01.htm</link><description>GENEVA (Reuters) - The World Health Organization (WHO) said on Friday that it would help Saudi Arabia dig deeper into deadly outbreaks of a new SARS-like virus to draw up advice ahead of the annual haj pilgrimage, which attracts millions of Muslims.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5d8066/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664395149/u/49/f/654207/c/35217/s/2c5d8066/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664395149/u/49/f/654207/c/35217/s/2c5d8066/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664395149/u/49/f/654207/c/35217/s/2c5d8066/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7xbgUaa5qWc:VOUko4lhiT0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7xbgUaa5qWc:VOUko4lhiT0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=7xbgUaa5qWc:VOUko4lhiT0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7xbgUaa5qWc:VOUko4lhiT0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=7xbgUaa5qWc:VOUko4lhiT0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/7xbgUaa5qWc" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 15:46:21 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-coronavirus-idUSBRE94N0MX20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c5d8066/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Ecoronavirus0EidUSBRE94N0AMX20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Novo obesity drug could launch in U.S. end 2014</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/dytn1fj0li0/story01.htm</link><description>COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c59b59c/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dytn1fj0li0:M-ur7juvH5o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dytn1fj0li0:M-ur7juvH5o:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=dytn1fj0li0:M-ur7juvH5o:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dytn1fj0li0:M-ur7juvH5o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=dytn1fj0li0:M-ur7juvH5o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/dytn1fj0li0" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 24 May 2013 10:50:41 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/24/us-novonordisk-obesity-idUSBRE94N0BU20130524?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c59b59c/l/0L0Sreuters0N0Carticle0C20A130C0A50C240Cus0Enovonordisk0Eobesity0EidUSBRE94N0ABU20A130A5240DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Aveo says partner Astellas will not seek EU nod for kidney cancer drug</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/HAYf8jxMLsg/story01.htm</link><description>(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53aa1e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=HAYf8jxMLsg:CTWGQQRRx6U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=HAYf8jxMLsg:CTWGQQRRx6U:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=HAYf8jxMLsg:CTWGQQRRx6U:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=HAYf8jxMLsg:CTWGQQRRx6U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=HAYf8jxMLsg:CTWGQQRRx6U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/HAYf8jxMLsg" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 22:49:25 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-aveo-study-idUSBRE94M19520130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53aa1e/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Eaveo0Estudy0EidUSBRE94M19520A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>California reveals prices for health insurance under Obamacare</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/M_TyVUs-V70/story01.htm</link><description>LOS ANGELES (Reuters) - California unveiled prices on Thursday that consumers will pay for a selection of health plans offered through the state under the Affordable Care Act, providing a glimpse into how health care reform may look as it is rolled out across the nation.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53dc77/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664792869/u/49/f/654207/c/35217/s/2c53dc77/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664792869/u/49/f/654207/c/35217/s/2c53dc77/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664792869/u/49/f/654207/c/35217/s/2c53dc77/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M_TyVUs-V70:5Z7kmre-o_c:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M_TyVUs-V70:5Z7kmre-o_c:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=M_TyVUs-V70:5Z7kmre-o_c:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M_TyVUs-V70:5Z7kmre-o_c:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=M_TyVUs-V70:5Z7kmre-o_c:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/M_TyVUs-V70" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 22:13:10 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-usa-healthcare-california-idUSBRE94M19X20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53dc77/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Eusa0Ehealthcare0Ecalifornia0EidUSBRE94M19X20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Lawmaker would give FDA more oversight of drug compounding</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/IapvRRyPrjw/story01.htm</link><description>WASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53db70/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=IapvRRyPrjw:IvYaP5tMtYE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=IapvRRyPrjw:IvYaP5tMtYE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=IapvRRyPrjw:IvYaP5tMtYE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=IapvRRyPrjw:IvYaP5tMtYE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=IapvRRyPrjw:IvYaP5tMtYE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/IapvRRyPrjw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 22:07:43 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-usa-health-compounding-pharmacies-idUSBRE94M19U20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c53db70/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Eusa0Ehealth0Ecompounding0Epharmacies0EidUSBRE94M19U20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>New J&amp;J anti-depressant related to 'Special K' party drug</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/NgVGdVPXgVQ/story01.htm</link><description>NEW BRUNSWICK, New Jersey (Reuters) - Johnson &amp; Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4e47d3/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=NgVGdVPXgVQ:EhnZg8ROSco:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=NgVGdVPXgVQ:EhnZg8ROSco:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=NgVGdVPXgVQ:EhnZg8ROSco:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=NgVGdVPXgVQ:EhnZg8ROSco:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=NgVGdVPXgVQ:EhnZg8ROSco:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/NgVGdVPXgVQ" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 21:12:12 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-johnsonjohnson-investors-idUSBRE94M0J120130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4e47d3/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ejohnsonjohnson0Einvestors0EidUSBRE94M0AJ120A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Sugar water injections may help ease knee pain</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/Y32alUsqeSM/story01.htm</link><description>NEW YORK (Reuters Health) - Knee pain appears to decrease up to one year after "prolotherapy," a series of sugar water injections at the site of the pain, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c537ebe/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664272969/u/49/f/654207/c/35217/s/2c537ebe/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664272969/u/49/f/654207/c/35217/s/2c537ebe/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664272969/u/49/f/654207/c/35217/s/2c537ebe/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Y32alUsqeSM:Je_UFJhgkmQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Y32alUsqeSM:Je_UFJhgkmQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y32alUsqeSM:Je_UFJhgkmQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Y32alUsqeSM:Je_UFJhgkmQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y32alUsqeSM:Je_UFJhgkmQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/Y32alUsqeSM" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 21:00:09 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-sugar-water-injections-idUSBRE94M16K20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c537ebe/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Esugar0Ewater0Einjections0EidUSBRE94M16K20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Online tool reduces inappropriate medical tests</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/mTeh4yFCu3U/story01.htm</link><description>NEW YORK (Reuters Health) - A web-based decision-making tool that alerts heart doctors when diagnostic tests would not be useful for a specific patient can curb wasteful procedures, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c533f6f/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mTeh4yFCu3U:0sHbPb_XrcE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mTeh4yFCu3U:0sHbPb_XrcE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mTeh4yFCu3U:0sHbPb_XrcE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mTeh4yFCu3U:0sHbPb_XrcE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mTeh4yFCu3U:0sHbPb_XrcE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/mTeh4yFCu3U" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 20:28:34 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-medical-tests-idUSBRE94M15P20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c533f6f/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Emedical0Etests0EidUSBRE94M15P20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Marijuana tied to better blood sugar control</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/bNrB4x9OwMk/story01.htm</link><description>NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels of insulin resistance - a diabetes precursor - than those who never tried the drug, in a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c52e3a3/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNrB4x9OwMk:M4R1f8cbhKo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNrB4x9OwMk:M4R1f8cbhKo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bNrB4x9OwMk:M4R1f8cbhKo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNrB4x9OwMk:M4R1f8cbhKo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bNrB4x9OwMk:M4R1f8cbhKo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/bNrB4x9OwMk" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 19:44:08 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-marijuana-diabetes-idUSBRE94M14C20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c52e3a3/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Emarijuana0Ediabetes0EidUSBRE94M14C20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Labs reject dramatic findings on cancer drug in Alzheimer's mice</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/fG7Y1zuF7Eg/story01.htm</link><description>CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c7/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fG7Y1zuF7Eg:4isPcmot8AM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fG7Y1zuF7Eg:4isPcmot8AM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=fG7Y1zuF7Eg:4isPcmot8AM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fG7Y1zuF7Eg:4isPcmot8AM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=fG7Y1zuF7Eg:4isPcmot8AM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/fG7Y1zuF7Eg" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 18:05:08 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-alzheimers-mice-idUSBRE94M0ZO20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c7/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ealzheimers0Emice0EidUSBRE94M0AZO20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>WHO warns countries not to hoard secrets of coronavirus</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/8lW1H6sVSuo/story01.htm</link><description>GENEVA (Reuters) - The World Health Organization (WHO) warned countries with possible cases of the SARS-like novel coronavirus on Thursday that they must share information and not allow commercial labs to profit from the virus, which has killed 22 people worldwide.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c5/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664787721/u/49/f/654207/c/35217/s/2c51c1c5/kg/342-363/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664787721/u/49/f/654207/c/35217/s/2c51c1c5/kg/342-363/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664787721/u/49/f/654207/c/35217/s/2c51c1c5/kg/342-363/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=8lW1H6sVSuo:PV_lIm_Ctew:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=8lW1H6sVSuo:PV_lIm_Ctew:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=8lW1H6sVSuo:PV_lIm_Ctew:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=8lW1H6sVSuo:PV_lIm_Ctew:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=8lW1H6sVSuo:PV_lIm_Ctew:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/8lW1H6sVSuo" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 18:04:20 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-coronavirus-who-idUSBRE94M0ZL20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c5/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ecoronavirus0Ewho0EidUSBRE94M0AZL20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>New advice didn't change breast screening rates</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/MKICKtfB7_g/story01.htm</link><description>NEW YORK (Reuters Health) - Women in their 40s didn't cut back on mammograms during 2010, the year after a government-backed panel said annual breast cancer screening should be optional for them, says a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c6/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MKICKtfB7_g:sAQ5GUeCd5g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MKICKtfB7_g:sAQ5GUeCd5g:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=MKICKtfB7_g:sAQ5GUeCd5g:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MKICKtfB7_g:sAQ5GUeCd5g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=MKICKtfB7_g:sAQ5GUeCd5g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/MKICKtfB7_g" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 18:02:37 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-breast-screening-idUSBRE94M0ZG20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51c1c6/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ebreast0Escreening0EidUSBRE94M0AZG20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Schools should make exercise 'core' subject, U.S. panel urges</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/MIi07MPUuq0/story01.htm</link><description>WASHINGTON (Reuters) - U.S. schools need to boost efforts to get students moving, and make gym class as critical as other core subjects if they want to increase test scores as well as students' general well-being, a leading group of health advisers said on Thursday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51cd58/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MIi07MPUuq0:hC5h2xaOJT4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MIi07MPUuq0:hC5h2xaOJT4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=MIi07MPUuq0:hC5h2xaOJT4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=MIi07MPUuq0:hC5h2xaOJT4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=MIi07MPUuq0:hC5h2xaOJT4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/MIi07MPUuq0" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 17:31:47 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-usa-education-exercise-idUSBRE94M0XB20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c51cd58/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Eusa0Eeducation0Eexercise0EidUSBRE94M0AXB20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Novo Nordisk says obesity drug trial confirms weight loss</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/M7B_F-eQUMc/story01.htm</link><description>COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c513c9d/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664267881/u/49/f/654207/c/35217/s/2c513c9d/kg/342-363/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664267881/u/49/f/654207/c/35217/s/2c513c9d/kg/342-363/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664267881/u/49/f/654207/c/35217/s/2c513c9d/kg/342-363/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M7B_F-eQUMc:1cd9Ko1yQpc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M7B_F-eQUMc:1cd9Ko1yQpc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=M7B_F-eQUMc:1cd9Ko1yQpc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=M7B_F-eQUMc:1cd9Ko1yQpc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=M7B_F-eQUMc:1cd9Ko1yQpc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/M7B_F-eQUMc" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 16:58:57 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-novonordisk-obesity-idUSBRE94M0VG20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c513c9d/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Enovonordisk0Eobesity0EidUSBRE94M0AVG20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Saudi Arabia confirms another death from SARS-like virus</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/raXaXJ9HaCc/story01.htm</link><description>DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to 17.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4df3ed/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=raXaXJ9HaCc:XeGBOOiwBmU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=raXaXJ9HaCc:XeGBOOiwBmU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=raXaXJ9HaCc:XeGBOOiwBmU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=raXaXJ9HaCc:XeGBOOiwBmU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=raXaXJ9HaCc:XeGBOOiwBmU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/raXaXJ9HaCc" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 15:56:38 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-coronavirus-idUSBRE94M0IN20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4df3ed/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ecoronavirus0EidUSBRE94M0AIN20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>BTG says interventional medicine buys could boost sales to $1 bln</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/qUfKKERnevE/story01.htm</link><description>LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4e47d7/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=qUfKKERnevE:C_tODA0G7AU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=qUfKKERnevE:C_tODA0G7AU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=qUfKKERnevE:C_tODA0G7AU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=qUfKKERnevE:C_tODA0G7AU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=qUfKKERnevE:C_tODA0G7AU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/qUfKKERnevE" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 12:07:11 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-btg-idUSBRE94M0J320130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4e47d7/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Ebtg0EidUSBRE94M0AJ320A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>GSK flu shot may raise adult narcolepsy risk: Finnish scientists</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/aVt2vSZsWgo/story01.htm</link><description>HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4daaac/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664773951/u/49/f/654207/c/35217/s/2c4daaac/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664773951/u/49/f/654207/c/35217/s/2c4daaac/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664773951/u/49/f/654207/c/35217/s/2c4daaac/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=aVt2vSZsWgo:bBFKod-Vppo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=aVt2vSZsWgo:bBFKod-Vppo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=aVt2vSZsWgo:bBFKod-Vppo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=aVt2vSZsWgo:bBFKod-Vppo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=aVt2vSZsWgo:bBFKod-Vppo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/aVt2vSZsWgo" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 11:13:34 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-gsk-vaccine-narcolepsy-idUSBRE94M0FJ20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c4daaac/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Egsk0Evaccine0Enarcolepsy0EidUSBRE94M0AFJ20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Pfizer takes its shot at a vaccine for evasive superbug</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/hOSSMGQWBUg/story01.htm</link><description>CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c490859/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=hOSSMGQWBUg:AWzGYNY4zjg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=hOSSMGQWBUg:AWzGYNY4zjg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=hOSSMGQWBUg:AWzGYNY4zjg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=hOSSMGQWBUg:AWzGYNY4zjg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=hOSSMGQWBUg:AWzGYNY4zjg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/hOSSMGQWBUg" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 23 May 2013 05:28:38 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/23/us-pfizer-vaccine-idUSBRE94M05J20130523?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c490859/l/0L0Sreuters0N0Carticle0C20A130C0A50C230Cus0Epfizer0Evaccine0EidUSBRE94M0A5J20A130A5230DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item></channel></rss>
